FR5564M - - Google Patents

Info

Publication number
FR5564M
FR5564M FR9154A FR9154A FR5564M FR 5564 M FR5564 M FR 5564M FR 9154 A FR9154 A FR 9154A FR 9154 A FR9154 A FR 9154A FR 5564 M FR5564 M FR 5564M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR9154A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR5564M publication Critical patent/FR5564M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
FR9154A 1964-03-14 1965-03-13 Expired FR5564M (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1427464 1964-03-14
JP4213164 1964-07-23

Publications (1)

Publication Number Publication Date
FR5564M true FR5564M (en) 1968-01-02

Family

ID=26350188

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9154A Expired FR5564M (en) 1964-03-14 1965-03-13

Country Status (3)

Country Link
FR (1) FR5564M (en)
GB (1) GB1038529A (en)
SE (1) SE329165B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0639474B2 (en) * 1983-03-04 1994-05-25 大塚化学株式会社 Method for producing cephalosporin compound
EP0214600B1 (en) * 1985-09-03 1992-12-02 Otsuka Kagaku Kabushiki Kaisha Cephalosporin derivatives
AT405283B (en) * 1997-04-04 1999-06-25 Biochemie Gmbh NEW CRYSTALLINE 7- (Z) - (2- (2-AMINOTHIAZOL-4-YL) -2-HYDROXYIMINOACETAMIDO) -3-VINYL-3-CEPHEM-4- CARBONIC ACID DICYCLOHEXYLAMMONIUM SALTS AND METHODS FOR THE PRODUCTION THEREOF
EP1842852A1 (en) 2002-08-13 2007-10-10 Sandoz AG A cefdinir intermediate

Also Published As

Publication number Publication date
DE1545794A1 (en) 1969-12-11
GB1038529A (en) 1966-08-10
DE1545794B2 (en) 1975-07-31
SE329165B (en) 1970-10-05

Similar Documents

Publication Publication Date Title
FR4570M (en)
FR5564M (en)
FR4645M (en)
AU442366B2 (en)
FR5395M (en)
BE613833A (en)
BE623398A (en)
BE642770A (en)
BE642741A (en)
BE642735A (en)
BE647971A (en)
BE47396A (en)
BE656929A (en)
BE507097A (en)
BE518974A (en)
BE554195A (en)
BE564626A (en)
BE584699A (en)
BE642974A (en)
BE603534A (en)
BE610935A (en)
BE636791A (en)
BE621510A (en)
BE622126A (en)
BE483969A (en)